PharmiWeb.com - Global Pharma News & Resources
19-Dec-2018

Global Bacterial (Pyogenic) Meningitis - API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - ResearchAndMarkets.com

The "Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

The Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Bacterial (Pyogenic) Meningitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Bacterial (Pyogenic) Meningitis

Coverage of API manufacturers for Bacterial (Pyogenic) Meningitis marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.

Emerging Phase III products for Bacterial (Pyogenic) Meningitis

This report provides a comprehensive understanding of the emerging Phase III therapies for Bacterial (Pyogenic) Meningitis which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Bacterial (Pyogenic) Meningitis: Overview

  • Risk Factors
  • Causes
  • Symptoms
  • Pathophysiology
  • Prognosis
  • Diagnosis
  • Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Clinical Trials
  • Regulatory Milestones
  • Product Development Activities
  • United States
  • Europe
  • Historical Global Sales
  • Forecasted Global Sales
5. Emerging Therapies (Phase III)
  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/fctc4c/global_bacterial?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181219005257/en/

Editor Details

Last Updated: 19-Dec-2018